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RESEARCH ARTICLE
Visualizing bovine leukemia virus 
(BLV)-infected cells and measuring BLV proviral 
loads in the milk of BLV seropositive dams
Sonoko Watanuki1,2, Shin‑nosuke Takeshima1,3,4, Liushiqi Borjigin1,5, Hirotaka Sato1,5, Lanlan Bai1,3, 
Hironobu Murakami1,6, Reiichiro Sato7, Hiroshi Ishizaki8, Yasunobu Matsumoto2 and Yoko Aida1,2,5* 
Abstract 
Bovine leukemia virus (BLV) infects cattle and causes serious problems for the cattle industry, worldwide. Vertical 
transmission of BLV occurs via in utero infection and ingestion of infected milk and colostrum. The aim of this study 
was to clarify whether milk is a risk factor in BLV transmission by quantifying proviral loads in milk and visualizing the 
infectivity of milk. We collected blood and milk from 48 dams (46 BLV seropositive dams and 2 seronegative dams) 
from seven farms in Japan and detected the BLV provirus in 43 blood samples (89.6%) but only 22 milk samples 
(45.8%) using BLV‑CoCoMo‑qPCR‑2. Although the proviral loads in the milk tended to be lower, a positive correlation 
was firstly found between the proviral loads with blood and milk. Furthermore, the infectivity of milk cells with BLV 
was visualized ex vivo using a luminescence syncytium induction assay (LuSIA) based on CC81‑GREMG cells, which 
form syncytia expressing enhanced green fluorescent protein (EGFP) in response to BLV Tax and Env expressions 
when co‑cultured with BLV‑infected cells. Interestingly, in addition to one BLV‑infected dam with lymphoma, syncytia 
with EGFP fluorescence were observed in milk cells from six BLV‑infected, but healthy, dams by an improved LuSIA, 
which was optimized for milk cells. This is the first report demonstrating the infectious capacity of cells in milk from 
BLV‑infected dams by visualization of BLV infection ex vivo. Thus, our results suggest that milk is a potential risk factor 
for BLV vertical spread through cell to cell transmission.
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Bovine leukemia virus (BLV) is the etiological agent for 
enzootic bovine leukemia (EBL), the most common neo-
plastic disease of cattle. It belongs to the Deltaretrovirus 
genus of the Retroviridae family, which also includes the 
human T cell leukemia virus types 1 and 2 [1, 2]. Approx-
imately 70% of the BLV-infected cattle show no clinical 
symptoms, whereas 30% of the infected cattle develop 
persistent lymphocytosis, which is typified by the poly-
clonal expression of non-neoplastic  CD5+ B lymphocyte 
cells, 2–5% of which form B cell leukemia/lymphoma 
after a long latency period [1, 2].
Although BLV infects cattle worldwide, effective treat-
ments and vaccines are not available for practical appli-
cation [2]. In Japan, a recent study showed that 40.9% 
of dairy cattle are infected with BLV [3]. As such, BLV 
causes serious problems for the cattle industry. For 
instance, BLV infection appears to reduce milk produc-
tion [4], and the annual economic loss to the cattle indus-
try were estimated at $525 million [5]. Therefore, EBL is 
listed by the World Organization for Animal Health as a 
problem disease [6, 7]. Under these circumstances, it is 
necessary to decipher the specific routes of BLV-trans-
mission to prevent the spread of infection and to reduce 
economic loss [1].
Cell-to-cell transmission is the most efficient route 
of BLV transmission. The virus is present in circulat-
ing peripheral blood lymphocytes of infected cattle, and 
both horizontal and vertical transmission often occur 
through infected blood [1]. Vertical transmission occurs 
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via dam-to-calf contact and through in utero infection of 
the fetus [8], and via the milk and colostrum of naturally-
infected cows [9–12]. Indeed, it was previously reported 
that BLV-infected cells were present in the milk and 
colostrum of BLV-positive dams, because inoculation of 
lambs with milk or viable milk cells from 24 dairy cattle 
naturally infected with BLV resulted in the detection of 
infectious virus in the milk of 17 cows [13]. Recently, BLV 
provirus was detected in field samples of milk and colos-
trum [14–16]. However, the resistance of calves to milk-
borne infection can be attributed to virus-neutralizing 
antibodies, which all calves nursed on BLV-positive dams 
acquire through the colostrum and retain in their serum 
for as long as 6 months [17, 18]. In addition, Konishi et al. 
demonstrated that antibodies in the milk and colostrum 
of BLV-positive dams could protect against BLV infec-
tion in vitro [19]. Therefore, BLV transmission via milk, 
as compared to contact transmission, occurs at a lower 
transmission efficiency (around 6–16%) [13, 20–22]. 
Thus, a critical assessment of these data fails to support 
the conclusion that BLV transmission occurs via milk. It 
is therefore essential to evaluate the infectivity of milk 
and colostrum from BLV-infected cows by performing a 
detailed in vitro examination of BLV transmission.
The infectivity of several viruses was successfully dem-
onstrated in previous studies [23–26]. For example, the 
measurement of the infectivity of human immunodefi-
ciency virus (HIV) is based on established reporter cell 
lines, such as TZM-bl cells, which are stably transfected 
with a plasmid containing a reporter gene with the HIV 
long terminal repeat (LTR) in its upstream promoter 
region that is expressed during HIV replication [25]. Sim-
ilarly, we developed a luminescence syncytium-induction 
assay (LuSIA) for assaying the BLV infectivity of CC81-
BLU3G cells, which form syncytia expressing enhanced 
green fluorescent protein (EGFP) when co-cultured 
with BLV-infected cells [27]. Furthermore, we success-
fully constructed a new LuSIA protocol that is quantita-
tive and more sensitive than our previous assay, based 
on CC81-GREMG cells harboring a reporter plasmid 
containing a mutation in the glucocorticoid-response 
element in the LTR U3 region of BLV [28]. This new tech-
nology enabled us to specifically evaluate the infectivity 
of peripheral blood mononuclear cells and white blood 
cells (WBCs) from BLV-infected cows. Unfortunately, 
no infectivity testing was performed on milk from BLV-
positive dams.
Genomic DNA can be extracted from various sources, 
including whole blood, milk, semen, saliva, nasal secre-
tions, and several organs [14–16, 29–37]. We previ-
ously developed a highly specific, accurate, and sensitive 
method for quantifying proviral loads for both known 
and novel BLV variants in animals naturally infected 
with BLV [31, 38–40], based on the use of coordination 
of common motifs (CoCoMo) primers. Using the BLV-
CoCoMo-qPCR-2 assay developed by us, we detected 
provirus in nasal and saliva samples from cattle with 
over 14 000 copies/105 cells and 18 000 copies/105 cells 
in blood samples, respectively [31], suggesting that these 
cows could be considered to be at a high-risk of BLV 
transmission via direct contact between infected and 
uninfected cattle. In addition, it appeared that provi-
ral loads correlated with both BLV infection and disease 
progression [27, 38, 39]. However, the efficacy of BLV-
CoCoMo-qPCR-2 assay has not yet been examined for 
milk samples from BLV-positive cows.
In recent years, the potential of foodborne spread of 
BLV from fresh unpasteurized milk and raw beef have 
increased concern about BLV infection control [14, 41]. 
The correlation between the blood of dam and the pres-
ence of BLV provirus in colostrum has recently been 
reported [12, 19]; however, the same remains unclear for 
milk from BLV-positive dam. Therefore, it is important to 
determine the risk of BLV transmission through milk by 
quantifying proviral loads in milk and by evaluating the 
infectivity of milk. This study was undertaken to evaluate 
the risk of BLV transmission via the milk of BLV-positive 
dams. We detected the BLV provirus in milk, and visual-
ized and evaluated the BLV infectivity via milk, using the 
technologies of BLV-CoCoMo-qPCR-2, and LuSIA based 
on CC81-GREMG cells, previously developed by us. The 
results of the present study would enable us to establish 
effective cattle-management policies for the control and 
eradication of BLV.
Materials and methods
Clinical animals and cell lines
Blood and milk samples were obtained from two BLV-
negative Holstein–Friesian cattle, 43 BLV-infected Hol-
stein–Friesian cattle without lymphoma, and three 
BLV-infected Holstein–Friesian cattle with lymphoma 
from seven farms in Japan (Table 1). CC81-GREMG cells, 
established from CC81 [28] and FLK-BLV cells, which 
are persistently infected with BLV, were cultured at 37 °C 
with 5%  CO2 in Dulbecco’s modified Eagle’s Medium 
(DMEM) (Thermo Fisher Scientific, Waltham, MA, 
USA), supplemented with 10% fetal bovine serum (FBS; 
Sigma-Aldrich, St. Louis, MO, USA).
Collection of blood sample, genomic DNA extraction, 
and isolation of plasma
Ethylenediaminetetraacetic acid (EDTA)-treated whole 
blood samples (300  µL) were used for genomic DNA 
extraction with Wizard Genomic DNA Purification Kit 
(Promega Corporation, Madison, WI, USA), according to 
the manufacturer’s instructions. Genomic DNA samples 
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were adjusted to 30 ng/µL for use in the BLV-CoCoMo-
qPCR-2 assay [38–40]. Separate portions of EDTA-
treated whole blood samples were used to separate the 
plasma.
Isolation of milk cells, genomic DNA extraction, and LuSIA 
experiments
To isolate the milk cells, 100 mL milk samples were stored 
at 4 °C for less than 24 h on the day of sampling, and the 
cream layer and proteins were removed by performing 
two sequential centrifugation steps at 4000 × g for 3 min 
in 50 mL sterile tubes. The pellets and remaining super-
natants were transferred to new 15-mL sterile tubes and 
centrifuged at 800 × g for 30 min, and the pellets of the 
milk sample were resuspended in 15 mL phosphate buff-
ered saline (PBS) and washed twice by centrifugation at 
620 × g for 5 min and at 350 × g for 5 min.
DNA was extracted from the milk cells using Wizard 
Genomic DNA Purification Kit (Promega) with 1.54 mg/
mL of dithiothreitol, following the manufacturer’s 
instructions. The quantity and quality of DNA samples 
extracted from milk sample was determined based on 
the A260/280 ratio using a Nanodrop Spectrophotometer 
ND-1000 (Thermo Fisher Scientific).
The milk cells were also analyzed by LuSIA testing [28]. 
These cells were resuspended in 1  mL of DMEM, sup-
plemented with 10% FBS and counted using a Neubauer 
chamber. CC81-GREMG cells were seeded at a density of 
5 × 104 cells/well in a 12-well plate (Thermo Fisher Sci-
entific) and cultured at 37  °C for 24  h, after which they 
were co-cultured with the collected milk cells at densi-
ties of 5 × 105, 1 × 105, and 2 × 104 cells/well in culture 
medium for three days. As a positive control, FLK-BLV 
cells were co-cultured with CC81-GREMG cells at a den-
sity of 5 × 104 cells/well for the same time, as described 
previously [27]. The culture medium was then replaced 
with fresh medium at 72  h and the cells were cultured 
for an additional 24  h. The cells were washed and fixed 
as described previously [27], and the fluorescent EGFP-
positive syncytia in each well were visually counted and 
scanned by EVOS2 florescence microscopy (Thermo 
Fisher Scientific) under a 20-fold objective.
To optimize for the milk cells, we developed a modi-
fied version of a conventional LuSIA with CC81-GREMG 
cells, which was optimized for milk cells in terms of (i) 
the number of CC81-GREMG cells, (ii) the number of 
milk cells, (iii) the co-culture period, and (iv) the stimula-
tion by pokeweed mitogen (PWM), as shown in Table 3.
Determination of the BLV proviral loads 
by BLV‑CoCoMo‑qPCR‑2 assay
The BLV proviral loads in the blood and milk sam-
ples were determined with the BLV-CoCoMo-qPCR-2 
assay (RIKEN Genesis, Kanagawa, Japan) [38–40] using 
THUNDERBIRD Probe qPCR Mix (Toyobo, Tokyo, 
Japan). All amplifications were performed on the Light 
 Cycler® 480 system II (Roche Diagnostics, Mannheim, 
Germany). The proviral loads were estimated as copy 
numbers present in  105 white blood cells and milk cells.
Detection of anti‑Env gp51 antibody by enzyme‑linked 
immunosorbent assay (ELISA)
An anti-BLV antibody ELISA Kit (JNC, Tokyo, Japan) 
was used to detect the anti-Env gp51 antibodies, accord-
ing to the manufacturer’s instructions.
Polymerase chain reaction (PCR) amplification 
and sequencing of BLV env gene fragments
Three cattle were randomly chosen for amplification of 
the BLV env gene. The partial BLV env genes of blood 
and milk DNA were amplified by nested PCR, and were 
purified and sequenced, as described previously [42]. 
GENETYX (GENETYX Corporation, Tokyo, Japan) and 
SEQUENCHER software (Hitachi High-technologies 
Corporation, Tokyo, Japan) were used for editing, align-
ment, and identification of the nucleotide sequences.
Statistical analysis
R package version 2.5.2. 2019 was used to calculate p 
value for the significance of the differences between 
groups. The correlation coefficient (r) was calculated 
using Excel with the PEARSON function.
Results
The quantity and quality of genomic DNA extraction 
in milk and blood from 48 dams
Blood and milk samples were collected from 48 dams 
from seven different farms in Japan (Table 1). The rate of 
Table 1 The BLV-seropositive rates of each farm in this 
study 
a Farm number 1 included three BLV-infected cattle with lymphoma.
b The positive rates for BLV antibodies were determined using an anti-BLV 
antibody ELISA Kit (JNC, Tokyo, Japan).
Farm Cattle no. used in this 
study
BLV‑seropositive rate 
of the indicated  farmsb, % 
(+/all)
1a 3 Not tested
2 14 15.4 (32/208)
3 12 57.4 (39/68)
4 7 59.7 (37/62)
5 3 54.5 (18/33)
6 7 51.2 (42/82)
7 2 14.9 (31/208)
Total 48
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detection of BLV antibodies in the plasma of dams from 
these farms ranged from 14.9 to 59.7%, as determined 
by conventional serological techniques, such as ELISA 
(Table 1). Genomic DNAs were extracted from milk cells 
isolated from 100  mL milk and from whole blood sam-
ples of 300 µL.
The quantity (total yield: A) and quality (A260/A280 
ratio: B, threshold value: C) of genomic DNA are shown 
in Figure 1. The average total DNA yields from 300 µL of 
blood and 100  mL of milk were 7.9 and 6.7  µg, respec-
tively (Figure 1A). The values of the A260/A280 ratio for 
genomic DNA extracted from blood and milk were 1.88 
and 1.87, respectively (Figure  1B), indicating that DNA 
extracted from milk and blood had the same quality. To 
test whether the quality of the extracted DNA was suit-
able for PCR amplification, and to examine the efficiency 
of amplification based on the threshold cycle (Ct) value, 
all the DNA samples were subjected to real-time PCR 
analysis of the bovine BoLA-DRA gene, using the BLV-
CoCoMo-qPCR-2 assay. BoLA-DRA was amplified from 
blood and milk samples from all the cattle tested with 
average Ct values of 22.12 and 22.37, respectively, indi-
cating that the quality of both the sample types was suit-
able for PCR amplification (Figure 1C).
Detection of BLV proviral loads in milk and blood
Next, BLV antibodies were determined in plasma samples 
from all the 48 cows by BLV antibody ELISA. Forty-six 
out of 48 cows (95.8%) were positive for the BLV antibod-
ies (Table  2). In parallel, all the samples were analyzed 
for BLV proviral loads using the BLV-CoCoMo-qPCR-2 
assay. Of these, 43 blood DNA samples were positive for 
the BLV provirus (89.6%), whereas only 22 DNA sam-
ples from the milk (45.8%) were BLV provirus-positive. 
In contrast, no BLV provirus was detected in milk DNA 
from two dams that were negative for both the BLV anti-
bodies and provirus.
The BLV proviral DNA was detected in both the blood 
and milk samples from 22 cattle; the proviral loads of 
blood samples (578–1.1 × 105  copies/105 cells; average, 
4.0 × 104 copies/105 cells) tended to be higher than those 
of milk samples (7–6.3 × 103  copies/105 cells; average, 
371.5 copies/105 cells) (Table 2).
Correlation of BLV proviral loads in milk and blood samples
The proviral load in the peripheral blood appeared to cor-
relate with both the BLV infection and disease progres-
sion [27, 38, 39]. Therefore, to examine whether the BLV 
proviral loads in the peripheral blood samples correlated 
with those in the milk samples, we constructed a scatter 
graph using samples from two uninfected and 45 infected 
cattle (excluding lymphoma cattle A1) and performed a 
linear-regression analysis. We omitted the lymphoma 
cattle A1 from this calculation because it had a tumor in 
the posterior quarter of the mammary gland, and because 
it exhibited a proviral load that was 15–50-fold higher 
than that measured in milk from other lymphoma cows, 
such as A2 and A3. As shown in Figure  2, the correla-
tion coefficient (r) was 0.5781 (p = 2.08 × 10−5), indicat-
ing that a correlation existed between the DNA proviral 
loads in milk and blood samples from the BLV-infected 
dams.
In addition, we detected the BLV provirus in milk sam-
ples from dams when the proviral loads in blood samples 
Figure 1 Scatter diagrams showing the quantity and quality of DNA in blood and milk. DNA samples were obtained from 2 BLV‑negative 
cattle in Farm 3, 43 BLV‑infected cattle without lymphoma in Farms 2–6, and 3 BLV‑infected cattle with lymphoma in Farm 1. A The average 
quantities of genomic DNA in blood and milk samples were 7.9 µg and 6.7 µg, respectively, as determined with a NanoDrop spectrophotometer 
ND‑1000. B The average A260/A280 ratios of genomic DNA in blood and milk were 1.88 and 1.87, respectively, as determined using a NanoDrop 
spectrophotometer ND‑1000. C The threshold cycle values of the blood and milk samples were 22.12 and 22.37, respectively, as indicated with the 
red bold lines.
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Table 2 Detection of the proviral load in blood and milk samples 
Sample Age (years) WBCa  (102/µL) LYMPHb  (102/
µL)
SCCc  (106/mL) BLV  antibodiese Proviral  loadf 
(copies/105 cells)
Blood Milk Plasma Blood Milk
BLV‑free cows
 K1 2 NTd NT 0.8 – 0 0
 K2 2 NT NT 1.3 – 0 0
BLV‑infected cows without lymphoma
 Y2 5 103 53 NT + 0 0
 N6 2 99 38 NT + 0 0
 N7 3 79 23 NT + 0 0
 Y3 7 96 38 NT + 51 0
 G14 6 59 12 NT + 54 0
 S7 9 61 28 NT + 61 0
 S6 4 91 38 NT + 68 0
 K3 3 120 41 1.7 + 112 0
 S5 2 80 42 NT + 361 0
 K4 5 69 41 1.6 + 390 0
 K5 5 74 34 1.6 + 578 32
 G9 2 108 75 NT + 1457 0
 S4 7 77 37 NT + 3622 0
 G11 4 90 16 NT + 6389 0
 N5 7 104 52 2.3 + 10 169 76
 G12 6 137 18 NT + 10 480 0
 G10 2 152 26 NT + 12 097 0
 S3 5 105 53 NT + 17 130 26
 G5 4 118 53 NT + 18 000 32
 G8 6 113 54 NT + 18 793 7
 K6 3 78 19 NT + 19 548 19
 S1 7 109 60 NT + 20 139 0
 K7 3 119 68 6.4 + 21 267 0
 G4 8 114 43 NT + 21 284 51
 G2 6 85 47 NT + 21 603 0
 G13 3 116 NT NT + 22 331 0
 G7 3 87 16 NT + 24 387 0
 GDF211 8 82 45 NT + 24 694 56
 G6 6 104 61 NT + 25 139 70
 S2 3 150 94 NT + 26 002 0
 N4 6 93 33 NT + 27 642 0
 Y1 8 72 28 NT + 34 831 64
 GDF349 6 142 83 NT + 35 859 66
 N2 4 158 92 NT + 35 758 83
 N1 3 86 38 NT + 37 707 159
 N3 2 134 89 2.0 + 39 024 0
 G3 7 106 45 NT + 39 237 43
 K8 3 175 120 1.2 + 53 985 179
 K9 4 214 131 NT + 58 734 0
 G1 5 168 105 9.1 + 65 000 95
 K10 5 206 140 1.2 + 72 014 54
 K11 7 NT NT 0.5 + 78 629 129
 K12 4 NT NT 1.0 + 84 479 47
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were approximately > 10  000  copies/105 cells (excluding 
K5) (Table 2).
Our results suggest that these cows may be considered 
as being at high-risk for BLV transmission via milk from 
naturally infected dams.
Comparison of the nucleotide sequences obtained 
from milk and blood samples
We tried to confirm whether PCR products amplified 
from milk samples in the BLV-CoCoMo-qPCR-2 assay 
were derived from BLV, and whether the nucleotide 
sequences of the products from milk and blood samples 
were identical in the same animals. The BLV gp51 env 
gene sequences have been detected in BLV seroposi-
tive cattle from different global locations and are widely 
used for molecular characterization and genotyping. 
Therefore, we determined partial sequences of BLV env 
from milk and blood samples using three different sam-
ples (A1, A2, and K12) and aligned these sequences 
with corresponding sequences from a reference strain, 
EF600696 (FLK-BLV; Figure  3). The results clearly 
showed that the partial BLV env sequences of the isolates 
from milk samples from all the three BLV-infected cows 
were completely identical to those from blood samples 
of the same animals. The sequencing results showed that 
the isolates identified in this study belonged to genotype 
1 [6].
Visualization of the BLV‑infected cells in milk 
from BLV‑positive dams by conventional LuSIA testing
We also evaluated the BLV infectivity of milk cells. To 
determine whether LuSIA is useful for assessing the BLV 
infectivity of milk cells from the BLV-infected dams, we 
performed a conventional LuSIA by co-cultivating CC81-
GREMG cells (5 × 104  cells/well) expressing EGFP with 
milk cells (5 × 105, 1 × 105, or 2 × 104 cells/well; obtained 
from 100  mL milk samples) for 4  days (Table  3). Ten 
BLV provirus-positive milk samples (from cows K5, K6, 
K8, K10, K11, K12, A1, A2, N1, and N5) and the five 
milk samples (from cows K1, K2, K3, K4, and K9) that 
were negative for the provirus were used in the LuSIA 
experiment. Interestingly, fluorescent syncytia were only 
observed when CC81-GREMG cells were co-cultured 
with milk cells from the BLV-positive cow, A1, which had 
lymphoma (Figure 4). In contrast, no fluorescent syncytia 
were detected in milk cells isolated from the other cows. 
In particular, cow A1 had a tumor in the posterior quar-
ter of the mammary gland and showed a proviral load in 
the milk (6340 copies/105 cells) that was higher than that 
in the blood (4500 copies/105 cells), as shown in Table 2. 
Although LuSIA testing with CC81-GREMG cells was 
useful for visualizing the BLV infectivity of milk cells, it 
a WBC: White blood cell.
b LYMPH: lymphocyte.
c SCC: somatic cell count.
d NT: not tested.
e ELISA testing was performed using an anti-BLV ELISA kit (JNC Inc.) targeting BLV gp51. +, positive for anti-BLV antibodies; −, negative for anti-BLV antibodies.
f Proviral loads per  105 cells in blood and milk were measured via BLV-CoCoMo-qPCR-2 assay (RIKEN Genesis) [40], using THUNDERBIRD Probe qPCR Mix (Toyobo).
Table 2 (continued)
Sample Age (years) WBCa  (102/µL) LYMPHb  (102/
µL)
SCCc  (106/mL) BLV  antibodiese Proviral  loadf 
(copies/105 cells)
Blood Milk Plasma Blood Milk
BLV‑infected cows with lymphoma
 A1 8 109 NT 4.5 + 4500 6340
 A2 6 196 157 2.5 + 65 782 422
 A3 5 NT NT NT + 111 564 125
Figure 2 Correlation between the BLV proviral loads in blood 
and milk. The proviral loads in milk and blood samples from 47 cattle 
in Farms 1–6 were measured by BLV‑CoCoMo‑qPCR‑2 and compared 
after normalization to the levels found in  105 cells. The bold line 
represents the approximate curve (r = correlation coefficient) and p 
value is indicated.
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was necessary to optimize the detection conditions for 
milk cells from other cows.
Visualization of the BLV‑infected cells in milk 
from BLV‑positive dams using an improved LuSIA
We next developed a modified version of a conventional 
LuSIA with CC81-GREMG cells that was optimized for 
milk cells in terms of (i) the number of CC81-GREMG 
cells, (ii) the number of milk cells, (iii) the co-cul-
ture period, and (iv) PWM  stimulation (Table  3). We 
selected three BLV-infected cows (N5, N1, and K11), 
which had proviral loads of 76, 159, and 129 copies/105 
cells in the milk, respectively (Table 2) and reanalyzed 
proviral loads in milk (Figure  5A). When the number 
Figure 3 DNA‑sequence alignment of the partial BLV gp51 env gene region isolated from blood and milk. The FLK‑BLV sequence 
(EF600696) is shown as reference at the top of the sequence alignment. DNA fragments derived from blood and milk samples of two BLV‑infected 
cattle with lymphoma (cows A1 and A2) and a BLV‑infected cow without lymphoma (cow K12). The nucleotide (nt) sequences were compared with 
the FLK‑BLV of gp51 env region (5078 nt–5599 nt). Sequence identity with the FLK‑BLV sequence is indicated with dots.
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of CC81-GREMG cells were reduced by 1 × 104 cells/
well in assays with 1 × 105, 5 × 105, or 1 × 106 milk cells/
well, and increasing the co-culture time to 5 days, fluo-
rescent syncytia were observed in milk cells from two 
of three cows, namely N1 (1 × 105 cells/well, Figure 5B, 
left panel) and N5 (5 × 105 cells/well or 1 × 106 cells/
well, data not shown), which were not detected using 
the conventional LuSIA protocol. By contrast, fluores-
cent syncytia were not observed in N5 (1 × 105 cells/
well) and K11 (1 × 105 cells/well) (Figure 5B left panels). 
Finally, we analyzed the effect of activating the B cells 
from cows N1, N5, and K11 via PWM stimulation (Fig-
ure 5B, right panels). We added 0.2, 1, 10, or 20 µg/mL 
of PWM to CC81-GREMG cells and co-cultured them 
with milk cells for 5  days. Fluorescent syncytia were 
observed in milk cells from all the three cattle when 
only 1 µg/mL of PWM was added during the co-culture 
of 1 × 104 CC81-GREMG cells/well and only 1 × 105 
milk cells/well among several cell concentrations of 
milk cells tested (Figure 5B, right panels). Interestingly, 
the fluorescent syncytia became detectable in milk cells 
from K11 for the first time, following cellular activation 
by PWM stimulation. In addition, milk cells from cows 
N1, N5, and K11 exhibited stronger fluorescence and 
formed larger and more number of syncytia after PWM 
stimulation. Thus, as shown in Table  3, the improved 
LuSIA protocol was optimized using 1 × 104 CC81-
GREMG cells/well, 1 × 105 milk cells/well, a 5-day co-
culture period, and stimulation with 1 µg/mL of PWM.
Finally, we applied the improved LuSIA to other 
three BLV-infected cows (K8, GDF211 and GDF349), 
with proviral loads of 30, 50 and 66 copies/105 cells in 
the milk, respectively, and successfully observed the 
fluorescent syncytia in milk cells from the three BLV-
infected cows tested (Figure  5A). The present data 
demonstrate that milk cells from BLV-positive dam 
have BLV infectivity.
Table 3 Differences in the conditions used for the 
conventional and improved LuSIAs with CC81-GREMG cells 
Parameter Conventional Improvement
The number of CC81‑GREMG 
cells
5 × 104 cells/well 1 × 104 cells/well
The number of cells in the milk 5 × 105, 1 × 105, 
and 2 × 104 
cells/well
1 × 105 cells/well
Days of co‑culture 96 h (4 days) 120 h (5 days)
Activation of B‑cells by poke‑
weed mitogen stimulation
None 1 µg/mL
Figure 4 BLV infectivity of milk cells from a BLV‑infected cow with lymphoma (A1) via conventional LuSIA. A Milk cells were isolated 
from 100 mL milk sample and were resuspended in 1 mL of DMEM. Then milk cells (1 × 105) were cultured for 4 days with CC81‑GREMG cells. 
Subsequently, the cells were fixed in 3.6% formaldehyde/PBS with Hoechst 33342. The fluorescent syncytia were observed using an EVOS2 
fluorescence microscope. FLK‑BLV cells, which were productively infected with BLV, were used as the positive control. Mock‑treated cells were used 
as the negative control. B Low‑magnification image of the white square in subpanel A1. The scale bars (white bars) signify 275 µm.
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Discussion
Based on the results of the present study on milk taken 
from BLV-infected dams, we arrive at two conclusions 
discussed below. First, the BLV provirus was detected 
in milk samples from 22 out of 48 cattle using the BLV-
CoCoMo-qPCR-2. In addition, the proviral load in milk 
was positively associated with that in the blood, indi-
cating that the proviral load in the peripheral blood is 
a useful marker of the proviral load of milk cells. Our 
results also show that it is difficult to detect BLV in 
milk as compared to blood samples. Previously, the 
correlation between the proviral load in the blood of 
dam and the presence of provirus in the colostrum was 
investigated [12]. This is the first report demonstrat-
ing a positive correlation between the proviral loads 
in normal milk and blood, in addition to the colos-
trum, among BLV-infected cattle. Second, the BLV 
infectivity of milk cells from seven BLV-infected dam 
was successfully determined ex  vivo using a LuSIA 
based on CC81-GREMG cells. Among the milk sam-
ples from 10 cows positive for the BLV provirus, the 
milk cells from one BLV-infected dam with lymphoma 
appeared to have infectivity, as determined by the con-
ventional LuSIA. Therefore, we developed a new and 
highly sensitive LuSIA, which was optimized for milk 
cells. Six BLV-infected, but healthy, dams without lym-
phoma appeared to have infectivity, as determined by 
the improved LuSIA. In particularly, we demonstrated 
that there is infectious capacity of cells in milk when 
the proviral loads in milk samples were at least 30 cop-
ies/105 cells, as shown in Figure 5. On the other hand, 
our current data show that there is infectious capac-
ity of cells in blood by the LuSIA when the proviral 
loads in blood are at least 4 copies/105 cells (Unpub-
lished data). This is the first report indicating the infec-
tious capacity of cells in milk from BLV-infected cows 
ex vivo. Thus, these results suggest that BLV transmis-
sion to cattle might be caused by the consumption of 
raw milk. However, it was previously reported that 
antibodies in milk and colostrum of BLV-positive dams 
appeared to protect against BLV infection in vitro [19]. 
Therefore, it is essential to evaluate the effect of neu-
tralizing antibody on the infectivity of milk samples by 
our improved LuSIA.
Our results provide a strong evidence that the BLV pro-
viral load in the milk is positively associated with the pro-
viral load in the peripheral blood. Interestingly, partial 
sequence analysis of the BLV gp51 env gene revealed that 
the BLV strains in milk samples were identical to those 
in the matched blood samples from all the three cows 
analyzed in this study. These results show that, although 
it is unknown whether peripheral blood or organs main-
tain BLV proliferation, BLV-infected cells derived from 
peripheral blood circulate throughout the body and are 
then distributed in the mammary glands in  vivo and, 
thus, milk includes BLV-infected cells. In addition, the 
proviral loads in the peripheral blood were reflected in 
the levels of BLV-infected cells in milk as well as nasal 
and saliva [31]. Thus, it appears that proviral loads in the 
peripheral blood represent a useful marker for following 
the dynamics of BLV-infected cells in vivo. In contrast, a 
previous study revealed that BLV provirus does not have 
any correlation with antibodies in plasma and milk sam-
ples [15].
This study clearly shows that, although the BLV pro-
virus was detected in milk cells, the frequency of detec-
tion (45.8%) was lower than that in blood (89.6%). In 
addition, the proviral loads in milk tended to be lower 
Figure 5 Infectivity of milk cells from BLV‑infected, healthy cows 
with our improved LuSIA using CC81‑GREMG cells. A The proviral 
loads in blood and milk, and the improved LuSIA results of milk cells 
for 6 BLV‑infected cattle without lymphoma (cows N1, K11, N5, K8, 
GDF211 and GDF349). B Typical visualization of the infectivity of milk 
cells from selected cows N1, K11, and N5 among 6 BLV‑infected dam 
tested in this study using our improved LuSIA protocol. The cells 
remaining in the supernatants were pelleted at 800 × g (cows N1 and 
K11) or 1000×g (cow N5) for 30 min. Milk cells (1 × 105) were cultured 
with 1 × 104 CC81‑GREMG cells with (+) or without (−) 1 µg/mL of 
PWM. After 5 days of co‑culturing CC81‑GREMG cells with milk cells, 
the cells were fixed in 3.6% formaldehyde/PBS with Hoechst 33342. 
Fluorescent syncytia were observed using an EVOS2 fluorescence 
microscope. +, more than two syncytia were observed in the milk 
cells. FLK‑BLV cells, which were productively infected with BLV, were 
used as the positive control. The scale bars (white and yellow bar) 
signify 100 µm or 650 µm.
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than those in the blood from the same animals. Like-
wise, previous reports showed that it was difficult to 
detect BLV in milk [14, 15]. For example, Kuckleburg 
et al. detected the BLV DNA in 82% and 59% of blood 
and milk samples, respectively, and the proviral loads 
in blood were significantly higher than those in milk 
[14]. The low proviral loads in milk might be explained 
by the presence of numerous components in milk (i.e., 
proteases, complex polysaccharides, lipids, and  Ca2+ 
ions) that can interfere with DNA extraction and qPCR 
analysis, thereby, decreasing the detection sensitiv-
ity compared to that in the blood. Indeed, interference 
with PCR amplification was previously demonstrated 
when the limit of detection of BLV qPCR was assessed 
in the presence of the BLV provirus in a milk matrix 
[16]. Another explanation for the differences in provi-
ral loads could be that less BLV-infected cells contain-
ing integrated BLV provirus are present in milk than 
in blood. Originally, data from Reber et  al. indicated 
that fewer B-lymphocytes (the main target cells of BLV 
infection) were present in milk than in blood [43]. In 
this study, we purified genomic DNA of the same qual-
ity from milk and blood samples, and the expression of 
BoLA-DRA gene was found to be identical by PCR of 
the DNA extracted from the blood and milk samples 
(Figure 1). Therefore, the possibility that blood contains 
a larger number of BLV-infected lymphocytes than milk 
might be the most reasonable.
In this study, we provide the first evidence that milk 
cells from seven BLV-infected dam had BLV infectiv-
ity ex vivo. The EBL cow, A1, had a tumor in the poste-
rior quarter of the mammary gland, a lymph node in the 
rear left breast, and a lymph node in the bilateral ilium 
(Figure 4). Furthermore, cow A1 showed a milk proviral 
load (6340 copies/105 cells) higher than that in the blood 
from the same cow and other milk samples. Consider-
ing this information, the proviral load in milk appeared 
to be really high among the 12 milk samples tested and, 
therefore, it might be possible to detect the BLV infectiv-
ity of milk cells from one EBL cattle via the conventional 
LuSIA. However, whether the observed disease symp-
toms were related to the detection of BLV infectivity in 
milk remains unclear. We also successfully visualized 
the BLV-infected milk cells from six BLV-positive, but 
healthy, dams without lymphoma using a highly sensi-
tive LuSIA optimized for milk cells. Collectively, the milk 
cells from these BLV-infected dams might include vari-
ous somatic cells, such as leukocytes and epithelial cells. 
Previous studies suggest that BLV has a broad host range; 
therefore it can successfully infect various cell types 
in vitro and in vivo [44, 45]. Therefore, it is necessary to 
clarify which cell types of lymphocytes and various other 
cells in the milk were infected by BLV.
In this study, we modified a conventional LuSIA with 
CC81-GREMG cells by varying the number of CC81-
GREMG cells, the number of milk cells, the co-culture 
period, and the stimulation by PWM. Decreasing the 
number of reporter cells seemed to increase the growth 
rate of reporter cells when compared with the con-
ventional LuSIA. Furthermore, larger syncytia formed 
because the BLV-infected milk cells easily contacted 
uninfected cells and CC81-GREMG cells when the 
number of milk cells per well was increased. Finally, 
the addition of PWM clearly induced the formation of 
several large syncytia. PWM exerts mitogenic activ-
ity on B and T cells and induces cellular prolifera-
tion [46], which may have promoted the activation of 
milk cells and their contact with an optimal number 
of reporter cells. The improved LuSIA protocol based 
on CC81-GREMG cells was optimized using 1 × 104 
CC81-GREMG cells/well, 1 × 105 milk cells/well, a 
5-day co-culture period, and stimulation with 1 µg/mL 
of PWM (Table 3). It could also detect BLV infectivity 
in milk cells with higher resolution than was achieved 
in our previous protocol. More comprehensive studies 
are needed to confirm the mechanism of vertical BLV 
transmission through milk.
The present study successfully demonstrates that milk 
cells from BLV-infected dams have infectious ability 
ex vivo. Since present findings show the same tendency 
as previous study that lambs could be infected with 
BLV when inoculated with colostrum and milk which 
derived from BLV-infected cattle [13], we may conclude 
that milk is a risk factor for BLV vertical spread through 
cell to cell transmission. Nonetheless, few samples 
were evaluated, additional studies with more animals 
are required to further confirm these findings. In this 
study, we developed a strategy for estimating the BLV 
infectivity in milk, which should be quite useful for 
developing new methods with milk from BLV-infected 
cows to protect calves from BLV infection.
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